Genomics - Global - World Health Organization (WHO) Genomics is evolving rapidly, and its potential impact for the future of human health cannot yet be known Human genomics knowledge and technologies provide new ways to prevent and manage many diseases, and opportunities to achieve global public health goals Genomic knowledge of other organisms contributes to the understanding of human health and diseases, the interconnectedness across
WHO releases new principles for ethical human genomic data collection . . . The World Health Organization (WHO) has issued a set of principles for the ethical collection, access, use and sharing of human genomic data Created with guidance from the WHO Technical Advisory Group on Genomics (TAG-G) and other international experts, these principles establish a global approach to help protect individual rights, promote equity and foster responsible collaboration in
WHO global genomic surveillance strategy for pathogens with pandemic . . . The Strategy provides a high-level unifying framework to leverage existing capacities, address barriers and strengthen the use of genomic surveillance in the detection, monitoring and response to public health threats Genomic surveillance is part of the broader surveillance and laboratory system, and its implementation should reinforce end-to-end capacities including sample collection
Genomics costing tool - World Health Organization (WHO) The first edition of the genomics costing tool (GCT) facilitates budgeting and resource mobilization for infrastructure, workforce, biosafety and quality assurance associated with SARS-CoV-2 genomic surveillance This tool will be useful to country, regional and global policymakers, health administrators and economists, laboratory directors, quality managers, donor institutions and other
Technical Advisory Group on Genomics (TAG-G) The Technical Advisory Group on Genomics (TAG-G) provides independent, strategic advice to WHO around technical areas relating to enhancing access to genomic knowledge and technologies for global health
WHO establishes communities of practice for pathogen genomics surveillance Within the pathogen genomics workstream, the group has focused on supporting harmonization and in-country deployment of the bioinformatics analysis of MPXV genome data to strengthen quality of the analysis Additionally, the group is developing a guidance document outlining analytical considerations for MPXV genomic surveillance
International Pathogen Surveillance Network (IPSN) The International Pathogen Surveillance Network (IPSN) is a global network of pathogen genomic actors, brought together by the WHO Hub for Pandemic and Epidemic Intelligence, to accelerate progress in pathogen genomics, and improve public health decision-making Pathogen genomic surveillance is the monitoring and analysis of the genetic material (the genome) of pathogens, such as viruses
News - World Health Organization (WHO) Abortion: Safety Accessing and implementing GCF readiness funds Addictive behaviours: Gaming disorder Adolescent health and development Adolescent sexual and reproductive health Ageing: Ageism Ageing: Global population Air pollution: Personal interventions and risk communication Air pollution: Reducing short-lived climate pollutants Antibiotic resistance: Why vaccination is important
Accelerating access to genomics for global health: promotion . . . This publication presents the recommendations of the WHO Science Council to the Director-General on accelerating access to genomics for global health A series of workshops was held in 2021 to gather information and perspectives on this topic Fifteen actions are recommended to achieve the goal of accelerating access to genomics for global health
Partner spotlight: Centre for Pathogen Genomics celebrates two years of . . . The Centre for Pathogen Genomics is a leading academic and training hub for infectious diseases genomics in the Asia-Pacific region at the University of Melbourne, based at the Doherty Institute The Centre’s mission is to build collaborative partnerships to support accessible pathogen genomics globally, through translational research and research training; and also to provide support for